Intracellular targeting, interaction with Src homology 3 (SH3) domains and rolipram-detected conformational switches in cAMP-specific PDE4A phosphodiesterase.

作者信息

Houslay M D, Scotland G, Erdogan S, Huston E, Mackenzie S, McCallum J F, McPhee I, Pooley L, Rena G, Ross A, Beard M, Peder A, Begg F, Wilkinson I, Yarwood S, Ackerman C, Houslay E S, Hoffman R, Engels P, Sullivan M, Bolger G

机构信息

Division of Biochemistry & Molecular Biology, IBLS, University of Glasgow, Scotland, U.K.

出版信息

Biochem Soc Trans. 1997 May;25(2):374-81. doi: 10.1042/bst0250374.

DOI:10.1042/bst0250374

PMID:9191121

Abstract

摘要

相似文献

Intracellular targeting, interaction with Src homology 3 (SH3) domains and rolipram-detected conformational switches in cAMP-specific PDE4A phosphodiesterase.

Biochem Soc Trans. 1997 May;25(2):374-81. doi: 10.1042/bst0250374.

The SH3 domain of Src tyrosyl protein kinase interacts with the N-terminal splice region of the PDE4A cAMP-specific phosphodiesterase RPDE-6 (RNPDE4A5).

Biochem J. 1996 Aug 15;318 ( Pt 1)(Pt 1):255-61. doi: 10.1042/bj3180255.

Phosphodiesterase 4 in macrophages: relationship between cAMP accumulation, suppression of cAMP hydrolysis and inhibition of [3H]R-(-)-rolipram binding by selective inhibitors.

Biochem J. 1996 Sep 1;318 ( Pt 2)(Pt 2):425-36. doi: 10.1042/bj3180425.

Multiplicity within cyclic nucleotide phosphodiesterases.

Biochem Soc Trans. 1996 Nov;24(4):1005-9. doi: 10.1042/bst0241005.

Association with the SRC family tyrosyl kinase LYN triggers a conformational change in the catalytic region of human cAMP-specific phosphodiesterase HSPDE4A4B. Consequences for rolipram inhibition.

J Biol Chem. 1999 Apr 23;274(17):11796-810. doi: 10.1074/jbc.274.17.11796.

Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase.

Mol Pharmacol. 1995 Oct;48(4):747-57.

Anti-inflammatory effects of the novel phosphodiesterase IV inhibitor RP 73401.

Int Arch Allergy Immunol. 1995 May-Jun;107(1-3):425-6. doi: 10.1159/000237066.

The N-terminal alternately spliced regions of PDE4A cAMP-specific phosphodiesterases determine intracellular targeting and regulation of catalytic activity.

Biochem Soc Trans. 1996 Nov;24(4):980-6. doi: 10.1042/bst0240980.

Rolipram inhibition of phosphodiesterase-4 activation.

Eur J Pharmacol. 1995 Jul 18;290(2):169-72. doi: 10.1016/0922-4106(95)90031-4.

Differential regulation of human monocyte-derived TNF alpha and IL-1 beta by type IV cAMP-phosphodiesterase (cAMP-PDE) inhibitors.

J Pharmacol Exp Ther. 1995 Mar;272(3):1313-20.

引用本文的文献

Phosphodiesterase 4 inhibitors and the treatment of asthma: where are we now and where do we go from here?

Drugs. 2000 Feb;59(2):193-212. doi: 10.2165/00003495-200059020-00004.

cAMP-specific phosphodiesterase HSPDE4D3 mutants which mimic activation and changes in rolipram inhibition triggered by protein kinase A phosphorylation of Ser-54: generation of a molecular model.

Biochem J. 1998 Jul 1;333 ( Pt 1)(Pt 1):139-49. doi: 10.1042/bj3330139.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验